IL2 and glioblastoma: As triggering of freshly isolated tumor-derived NK-cells in glioblastomas is substantially impaired, we also postulated that IL-2 signaling is required to upregulate activating receptors on tumor-derived NK-cells in glioblastomas as has been previously reported for other tumor entities37–39.